These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17878760)

  • 1. Electrophysiologic actions of d,l-sotalol and GLG-V-13 in ischemically injured canine epicardium.
    Patterson E; Scherlag BJ; Lazzara R; Garrison GL; Berlin KD
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):304-13. PubMed ID: 17878760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic actions of BRB-I-28 in ischemically injured canine myocardium.
    Patterson E; Scherlag BJ; Berlin KD; Lazzara R
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):637-46. PubMed ID: 7681911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
    Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class III electrophysiologic actions of imidazole-substituted diheterabicyclononanes in canine myocardium.
    Patterson E; Scherlag BJ; Sangiah S; Garrison GL; Couch KM; Berlin KD; Lazzara R
    J Pharmacol Exp Ther; 1997 Apr; 281(1):155-62. PubMed ID: 9103493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic actions of clofilium and lidocaine in ischemically injured canine epicardium.
    Patterson E; Scherlag BJ; Lazzara R
    J Pharmacol Exp Ther; 1992 Jul; 262(1):375-82. PubMed ID: 1625209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological actions of BRB-I-28 in canine myocardial tissues.
    Patterson E; Scherlag BJ; Berlin KD; Lazzara R
    J Pharmacol Exp Ther; 1991 Nov; 259(2):558-65. PubMed ID: 1941607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta receptor blockade potentiates the antiarrhythmic actions of d-sotalol on reentrant ventricular tachycardia in a canine model of myocardial infarction.
    Kassotis J; Sauberman RB; Cabo C; Wit AL; Coromilas J
    J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1233-44. PubMed ID: 14678141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological characterization of a novel class III antiarrhythmic agent, GLG-V-13 in the mammalian heart.
    Fazekas T; Scherlag BJ; Carlsson L; Mabo P; Patterson E; Berlin KD; Lazzara R
    Acta Physiol Hung; 1995; 83(1):13-30. PubMed ID: 7660832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. d,l-Sotalol at therapeutic concentrations facilitates the occurrence of long-lasting non-stationary reentry during ventricular fibrillation in isolated rabbit hearts.
    Hsieh YC; Horng TL; Lin SF; Lin TC; Ting CT; Wu TJ
    Circ J; 2009 Jan; 73(1):39-47. PubMed ID: 19008631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent effect of acute ventricular dilatation on the electrophysiologic characteristics of d,l-sotalol and flecainide in the isolated rabbit heart.
    Eckardt L; Haverkamp W; Göttker U; Madeja M; Johna R; Borggrefe M; Breithardt G
    J Cardiovasc Electrophysiol; 1998 Apr; 9(4):366-83. PubMed ID: 9581953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular electrophysiologic responses of isolated neonatal and adult cardiac fibers to d-sotalol.
    Yabek SM; Kato R; Ikeda N; Singh BN
    J Am Coll Cardiol; 1988 May; 11(5):1094-9. PubMed ID: 3356828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lidocaine and diltiazem on recovery of electrophysiologic activity during partial reperfusion following severe myocardial ischemia in canine hearts.
    Murasato Y; Nagamoto Y; Urabe T; Kuraoka F; Nakashima Y; Kuroiwa A
    J Electrocardiol; 1997 Apr; 30(2):113-25. PubMed ID: 9141606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of D-sotalol on endocardial and epicardial action potentials of human ventricular myocardium in dilated cardiomyopathy.
    Montero M; Schmitt C
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):883-9. PubMed ID: 7898069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. d-Sotalol terminates reentry by two mechanisms with different dependence on the duration of the excitable gap.
    Fei H; Frame LH
    J Pharmacol Exp Ther; 1996 Apr; 277(1):174-85. PubMed ID: 8613916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate and time dependent effects of D-sotalol on the monophasic action potential after sudden increase of the heart rate.
    Melichercik J; Brachmann J; Schöls W; Hilbel T; Beyer T; Kübler W
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 1):65-72. PubMed ID: 9990602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of acute ventricular dilatation and d-sotalol during sustained reentrant ventricular tachycardia around a fixed obstacle.
    Reiter MJ; Zetelaki Z; Kirchhof CJ; Boersma L; Allessie MA
    Circulation; 1994 Jan; 89(1):423-31. PubMed ID: 7506639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemia-induced action potential shortening is blunted by d-sotalol in a pig model of reversible myocardial ischemia.
    Geelen P; O'Hara GE; Plante S; Philippon F; Gilbert M; Turgeon J
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):638-45. PubMed ID: 10774796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic and arrhythmogenic actions of methyl lidocaine during the recovery phase after canine myocardial infarction.
    Patterson E; Gibson JK; Lucchesi BR
    Pharmacology; 1988; 36(2):73-83. PubMed ID: 3353442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.